Randomized controlled trial comparing conventional antibiotic strategies versus regimens guided by epidemiological surveillance in infected patients with cirrhosis.

Imagine you're in hospital with a serious liver condition called cirrhosis, and you get a bacterial infection. Doctors want to treat it effectively, but they also want to prevent the germs from becoming resistant to antibiotics. When germs become resistant, the medicines stop working, making future infections much harder to treat.

This study is looking at two ways of choosing antibiotics for patients like you. One way is the standard treatment that doctors typically use. The other way involves using up-to-date information about what types of germs are common in the hospital or community at that time. The idea is that if doctors know which germs are likely to be causing the infection, they might be able to pick the most effective antibiotic straight away, which could help stop resistance from developing.

The main thing researchers want to find out is whether one of these approaches leads to fewer people developing antibiotic resistance within 28 days. They'll also be tracking other important things like how well the infection clears up, how long people need to stay in hospital, if they need intensive care, and how their overall health and liver scores change. They'll also look at the costs involved and any side effects from the antibiotics.